Teleflex Inc (TFX)

$103.05 -0.85 (-0.82%)
Market Cap 4.59B
Revenue (ttm) 3.05B
Net Income (ttm) 69.68M
EPS (ttm) N/A
PE Ratio 7.65
Forward PE 7.22
Profit Margin 2.29%
Debt to Equity Ratio 0.70
Volume 1,065,700
Avg Vol 806,398
Day's Range N/A - N/A
Shares Out 44.19M
Stochastic %K 1%
Beta 0.93
Analysts Sell
Price Target $132.38

Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also of...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610-225-6800
Address:
550 East Swedesford Road, Suite 400, Wayne, United States
BillionerOfKing
BillionerOfKing Jan. 14 at 6:26 PM
$TFX Current Stock Price: $103.14 Contracts to trade: $100 TFX Jan 16 2026 Call Entry: $2.55 Exit: $4.33 ROI: 70% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
medguy
medguy Jan. 8 at 6:37 PM
Out with small gains $TFX
0 · Reply
medguy
medguy Jan. 8 at 3:12 PM
Looking for a bounce $RGC $TFX
0 · Reply
bluffmeariver
bluffmeariver Jan. 8 at 2:19 PM
$TFX why crashing
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 4:05 PM
Truist Securities updates rating for Teleflex ( $TFX ) to Hold, target set at 120 → 135.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 1:27 PM
$TFX down 29.9% over the past year — is it a buying opportunity or a value trap? 🤔 📉 High debt & FX headwinds remain concerns 📈 UroLift & Barrigel drive growth in prostate care with expanding global presence 💡 5.4% average earnings surprise over the trailing four quarters See what makes the investment case strong for Teleflex 👉 https://www.zacks.com/stock/news/2805395/should-you-retain-teleflex-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2805395-body-25111&ADID=SYND_STOCKTWITS_TWEET_2_2805395_BODY_25111
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 12:27 PM
$TFX: Long-term story intact — but is the pressure worth it right now? ⚖️ UroLift expansion and Barrigel traction are supporting long-term growth, but high debt levels and FX headwinds are keeping the stock under pressure and clouding the near-term picture. Weigh the upside vs. the risks here 👉 https://www.zacks.com/stock/news/2805395/should-you-retain-teleflex-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2805395-teaser-25110&ADID=SYND_STOCKTWITS_TWEET_2_2805395_TEASER_25110
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 8:11 PM
Wells Fargo updates rating for Teleflex ( $TFX ) to Equal-Weight, target set at 114 → 139.
0 · Reply
IN0V8
IN0V8 Dec. 10 at 4:51 PM
$TFX Wells Fargo raises target price to $139 from $114
0 · Reply
PickAlpha
PickAlpha Dec. 10 at 12:59 PM
PickAlpha Morning Report | 2025-12-10 — 5 material moves and analysis • API reports U S crude inventories down 4 8mn — $XOP, $USO • Teleflex to sell units for 2 03bn and buyback — $TFX, $XLV • EIA updates 2025 26 liquids production and inventories — $XLE, $XOP • Etc.. https://open.substack.com/pub/pickalpha/p/pickalpha-morning-report-2025-12-dcc?r=1m2m41&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
0 · Reply
Latest News on TFX
Teleflex Announces Leadership Transition

Jan 8, 2026, 6:30 AM EST - 6 days ago

Teleflex Announces Leadership Transition

Teleflex: Selling, But How Much?

Dec 10, 2025, 4:18 PM EST - 5 weeks ago

Teleflex: Selling, But How Much?

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Dec 9, 2025, 9:20 AM EST - 5 weeks ago

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Teleflex to sell three of its businesses for $2.03 billion

Dec 9, 2025, 9:12 AM EST - 5 weeks ago

Teleflex to sell three of its businesses for $2.03 billion

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Dec 9, 2025, 9:04 AM EST - 5 weeks ago

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 7:18 AM EST - 2 months ago

Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript

Nov 14, 2025, 1:21 PM EST - 2 months ago

Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript

Teleflex to Present at the Jefferies Global Healthcare Conference in London

Nov 14, 2025, 6:30 AM EST - 2 months ago

Teleflex to Present at the Jefferies Global Healthcare Conference in London

These Analysts Cut Their Forecasts On Teleflex Following Q3 Results

Nov 7, 2025, 2:41 PM EST - 2 months ago

These Analysts Cut Their Forecasts On Teleflex Following Q3 Results

Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:16 AM EST - 2 months ago

Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript

Teleflex Announces Quarterly Dividend

Nov 6, 2025, 6:45 AM EST - 2 months ago

Teleflex Announces Quarterly Dividend

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

Nov 6, 2025, 6:30 AM EST - 2 months ago

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

Oct 16, 2025, 4:30 PM EDT - 3 months ago

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Sep 11, 2025, 6:30 AM EDT - 4 months ago

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 12:21 PM EDT - 4 months ago

Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 6:30 AM EDT - 5 months ago

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Aug 19, 2025, 6:30 AM EDT - 5 months ago

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript

Jul 31, 2025, 7:14 PM EDT - 5 months ago

Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Jul 31, 2025, 6:30 AM EDT - 5 months ago

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax

Jul 25, 2025, 11:15 AM EDT - 6 months ago

Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

Jul 17, 2025, 6:30 AM EDT - 6 months ago

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

Jul 1, 2025, 6:30 AM EDT - 7 months ago

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

Jun 12, 2025, 6:30 AM EDT - 7 months ago

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

Jun 11, 2025, 6:30 AM EDT - 7 months ago

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

Teleflex Publishes 2024 Global Impact Report

May 19, 2025, 6:30 AM EDT - 8 months ago

Teleflex Publishes 2024 Global Impact Report

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation

May 15, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

May 15, 2025, 6:30 AM EDT - 8 months ago

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 14, 2025, 10:00 AM EDT - 8 months ago

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation

May 13, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

May 13, 2025, 6:30 AM EDT - 8 months ago

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect

May 12, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect

May 11, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation

May 9, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation

May 8, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 7, 2025, 10:00 AM EDT - 9 months ago

Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm

May 7, 2025, 9:31 AM EDT - 9 months ago

TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation

May 5, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Investors to Inquire about Securities Investigation

May 4, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Investors to Reach Out

May 2, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Investors to Reach Out

Teleflex Incorporated (TFX) Q1 2025 Earnings Call Transcript

May 1, 2025, 3:13 PM EDT - 9 months ago

Teleflex Incorporated (TFX) Q1 2025 Earnings Call Transcript

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Stockholders to Reach Out

May 1, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teleflex Incorporated (TFX) And Encourages Stockholders to Reach Out

Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

May 1, 2025, 6:30 AM EDT - 9 months ago

Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Stockholders to Connect

Apr 30, 2025, 10:30 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Stockholders to Connect

Teleflex to Present at the BofA Securities 2025 Health Care Conference

Apr 30, 2025, 6:45 AM EDT - 9 months ago

Teleflex to Present at the BofA Securities 2025 Health Care Conference

Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device

Apr 30, 2025, 6:30 AM EDT - 9 months ago

Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device

BillionerOfKing
BillionerOfKing Jan. 14 at 6:26 PM
$TFX Current Stock Price: $103.14 Contracts to trade: $100 TFX Jan 16 2026 Call Entry: $2.55 Exit: $4.33 ROI: 70% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
medguy
medguy Jan. 8 at 6:37 PM
Out with small gains $TFX
0 · Reply
medguy
medguy Jan. 8 at 3:12 PM
Looking for a bounce $RGC $TFX
0 · Reply
bluffmeariver
bluffmeariver Jan. 8 at 2:19 PM
$TFX why crashing
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 4:05 PM
Truist Securities updates rating for Teleflex ( $TFX ) to Hold, target set at 120 → 135.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 1:27 PM
$TFX down 29.9% over the past year — is it a buying opportunity or a value trap? 🤔 📉 High debt & FX headwinds remain concerns 📈 UroLift & Barrigel drive growth in prostate care with expanding global presence 💡 5.4% average earnings surprise over the trailing four quarters See what makes the investment case strong for Teleflex 👉 https://www.zacks.com/stock/news/2805395/should-you-retain-teleflex-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2805395-body-25111&ADID=SYND_STOCKTWITS_TWEET_2_2805395_BODY_25111
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 12:27 PM
$TFX: Long-term story intact — but is the pressure worth it right now? ⚖️ UroLift expansion and Barrigel traction are supporting long-term growth, but high debt levels and FX headwinds are keeping the stock under pressure and clouding the near-term picture. Weigh the upside vs. the risks here 👉 https://www.zacks.com/stock/news/2805395/should-you-retain-teleflex-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2805395-teaser-25110&ADID=SYND_STOCKTWITS_TWEET_2_2805395_TEASER_25110
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 8:11 PM
Wells Fargo updates rating for Teleflex ( $TFX ) to Equal-Weight, target set at 114 → 139.
0 · Reply
IN0V8
IN0V8 Dec. 10 at 4:51 PM
$TFX Wells Fargo raises target price to $139 from $114
0 · Reply
PickAlpha
PickAlpha Dec. 10 at 12:59 PM
PickAlpha Morning Report | 2025-12-10 — 5 material moves and analysis • API reports U S crude inventories down 4 8mn — $XOP, $USO • Teleflex to sell units for 2 03bn and buyback — $TFX, $XLV • EIA updates 2025 26 liquids production and inventories — $XLE, $XOP • Etc.. https://open.substack.com/pub/pickalpha/p/pickalpha-morning-report-2025-12-dcc?r=1m2m41&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 9 at 5:08 PM
$TFX Current Stock Price: $131.83 Contracts to trade: $130 TFX Dec 19 2025 Call Entry: $5.00 Exit: $8.10 ROI: 62% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
smartkarma
smartkarma Dec. 9 at 4:02 PM
$TFX | Teleflex: What’s Powering Its Explosive Vascular Intervention Expansion? "Teleflex Inc. released its third-quarter 2025 results amidst its ongoing corporate transformation strategy. The company continues to progress with..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/teleflex-what-s-powering-its-explosive-vascular-intervention-expansion
0 · Reply
notreload_ai
notreload_ai Dec. 9 at 2:23 PM
$TFX announces $2.03B sale of Acute Care, Interventional Urology, and OEM businesses to streamline operations and focus on core medical technology markets while returning capital to shareholders. https://notreload.xyz/teleflex-sells-3-units-for-2b-announces-1b-buyback/
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 9 at 2:05 PM
$TFX (+0.9% pre) Teleflex to sell three business units for $2.03 billion https://ooc.bz/l/86815
0 · Reply
Estimize
Estimize Nov. 24 at 1:03 PM
Wall St is expecting 3.84 EPS for $TFX Q4 [Reporting 02/19 BMO] http://www.estimize.com/intro/tfx?chart=historical&metric_name=eps&utm_cont
0 · Reply
JackDarwin
JackDarwin Nov. 19 at 12:43 PM
$TFX Bullish Engulfing Candlestick Pattern formed at Downtrend. Wait for the confirmation from the next day's candle.
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:09 PM
Truist Securities updates rating for Teleflex ( $TFX ) to Hold, target set at 128 → 120.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 11:14 PM
$TFII $TFX $THC $THNQ $TJX
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:31 PM
RBC Capital has updated their rating for Teleflex ( $TFX ) to Sector Perform with a price target of 120.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:48 PM
Wells Fargo has updated their rating for Teleflex ( $TFX ) to Equal-Weight with a price target of 114.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 5:58 PM
$TELL $TEM $TFII $TFX $THC
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 3 at 3:11 PM
$TFX Share Price: $121.98 Contract Selected: Apr 17, 2026 $120 Calls Buy Zone: $11.13 – $13.76 Target Zone: $18.12 – $22.14 Potential Upside: 54% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply